Alnylam Pharmaceuticals, Inc.
DE ˙ XTRA ˙ US02043Q1076
251,80 € ↑6,70 (2,73%)
2026-06-03
DEL PRIS
SecurityDE:DUL / Alnylam Pharmaceuticals, Inc.
InstitutionMillennium Management Llc
ManagerIsrael Englander
Latest Disclosed Ownership447,887 shares
Latest Disclosed Value $ 148,192,372
Millennium Management Llc ownership in DUL / Alnylam Pharmaceuticals, Inc.

On May 15, 2026 - Millennium Management Llc filed a 13F-HR form disclosing ownership of 447,887 shares of Alnylam Pharmaceuticals, Inc. (DE:DUL) valued at $127,961,316 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 75,430 shares of Alnylam Pharmaceuticals, Inc.. This represents a change in shares of 493.78% during the quarter. The current value of the position is $112,777,947 USD.

Millennium Management Llc has a history of taking positions in derivatives of the underlying security (DUL) in the form of stock options. The firm currently holds call options representing 22,400 of underlying shares valued at $7,411,488 USD and put options representing 22,800 of underlying shares valued at $7,543,836 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

DE:DUL / Alnylam Pharmaceuticals, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 447,887 372,457 493.78 148,192 394.07 0.0617
2026-02-17 2025-12-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 75,430 -474,501 -86.28 29,995 -88.04 0.0126
2025-11-14 2025-09-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 549,931 459,486 508.03 250,769 750.26 0.1070
2025-08-14 2025-06-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 90,445 -196,892 -68.52 29,493 -61.99 0.0142
2025-05-15 2025-03-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 287,337 -46,105 -13.83 77,587 -1.12 0.0413
2025-02-14 2024-12-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 333,442 82,479 32.87 78,462 13.68 0.0383
2024-11-14 2024-09-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 250,963 112,459 81.20 69,022 105.08 0.0327
2024-08-14 2024-06-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 138,504 -63,774 -31.53 33,656 11.33 0.0156
2024-05-15 2024-03-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 202,278 165,742 453.64 30,230 332.29 0.0129
2024-02-14 2023-12-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 36,536 20,429 126.83 6,993 145.20 0.0030
2023-11-14 2023-09-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 16,107 -58,873 -78.52 2,853 -79.97 0.0014
2023-08-14 2023-06-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 74,980 51,606 220.78 14,242 204.16 0.0070
2023-05-15 2023-03-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 23,374 23,374 4,682 0.0027
2023-02-14 2022-12-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 0 -172,770 -100.00 0 -100.00
2022-11-14 2022-09-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 172,770 168,318 3,780.73 34,582 5,228.51 0.0205
2022-08-15 2022-06-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 4,452 -59,505 -93.04 649 -93.79 0.0004
2022-05-16 2022-03-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 63,957 -19,460 -23.33 10,444 -26.17 0.0055
2022-02-14 2021-12-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 83,417 71,585 605.01 14,146 533.21 0.0072
2021-11-15 2021-09-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 11,832 1,711 16.91 2,234 30.19 0.0013
2021-08-16 2021-06-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 10,121 -65,659 -86.64 1,716 -83.96 0.0011
2021-05-17 2021-03-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 75,780 -44,563 -37.03 10,699 -31.60 0.0077
2021-02-16 2020-12-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 120,343 115,143 2,214.29 15,641 1,966.18 0.0113
2020-11-16 2020-09-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 5,200 839 19.24 757 17.18 0.0009
2020-08-14 2020-06-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 4,361 -96,410 -95.67 646 -94.11 0.0009
2020-05-14 2020-03-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 100,771 -17,491 -14.79 10,969 -19.46 0.0246
2020-02-14 2019-12-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 118,262 -98,962 -45.56 13,620 -22.03 0.0170
2019-11-14 2019-09-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 217,224 63,166 41.00 17,469 56.28 0.0276
2019-08-15 2019-06-30 13F/A-1 ALNYLAM PHARMACEUTICALS COM 02043Q107 154,058 154,058 11,178 0.0168
2019-08-14 2019-06-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 154,058 154,058 11,178
2019-05-14 2019-03-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 0 -11,373 -100.00 0 -100.00
2019-02-15 2018-12-31 13F/A-1 ALNYLAM PHARMACEUTICALS COM 02043Q107 11,373 11,373 829 0.0013
2019-02-14 2018-12-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 11,373 829
2018-11-14 2018-09-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 0 -2,182 -100.00 0 -100.00
2018-08-14 2018-06-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 2,182 2,182 215 0.0003
2018-02-14 2017-12-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 0 -51,125 -100.00 0 -100.00
2017-11-14 2017-09-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 51,125 51,125 6,007 0.0092
2017-08-14 2017-06-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 0 -11,631 -100.00 0 -100.00
2017-05-15 2017-03-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 11,631 -217,609 -94.93 596 -93.06 0.0011
2017-02-14 2016-12-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 229,240 217,283 1,817.20 8,583 959.63 0.0180
2016-11-14 2016-09-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 11,957 -68,416 -85.12 810 -81.84 0.0014
2016-08-15 2016-06-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 80,373 -162,830 -66.95 4,460 -70.78 0.0102
2016-05-16 2016-03-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 243,203 206,690 566.07 15,266 344.17 0.0382
2016-02-16 2015-12-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 36,513 36,513 0.00 3,437 0.0072
2015-11-16 2015-09-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 0 -50,950 -100.00 0 -100.00
2015-08-14 2015-06-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 50,950 -28,565 -35.92 6,107 -26.45 0.0116
2015-05-15 2015-03-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 79,515 79,515 0.00 8,303 0.0154
2014-11-14 2014-09-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 0 -20,313 -100.00 0 -100.00
2014-08-14 2014-06-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 20,313 -107,042 -84.05 1,283 -85.00 0.0036
2014-05-15 2014-03-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 127,355 121,944 2,253.63 8,551 2,357.18 0.0248
2014-02-14 2013-12-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 5,411 -62,562 -92.04 348 -92.00 0.0011
2013-11-14 2013-09-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 67,973 67,973 4,351 0.0140
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F ALNYLAM PHARMACEUTICALS COM Call 22,400 138.30 7,411 98.31 n/a n/a n/a
2026-02-17 2025-12-31 13F ALNYLAM PHARMACEUTICALS COM Call 9,400 -73.52 3,738 -76.91 n/a n/a n/a
2025-11-14 2025-09-30 13F ALNYLAM PHARMACEUTICALS COM Call 35,500 -21.29 16,188 10.08 n/a n/a n/a
2025-08-14 2025-06-30 13F ALNYLAM PHARMACEUTICALS COM Call 45,100 -25.33 14,707 -9.83 n/a n/a n/a
2025-05-15 2025-03-31 13F ALNYLAM PHARMACEUTICALS COM Call 60,400 4,214.29 16,309 4,857.14 n/a n/a n/a
2025-02-14 2024-12-31 13F ALNYLAM PHARMACEUTICALS COM Call 1,400 -81.33 329 -84.04 n/a n/a n/a
2024-11-14 2024-09-30 13F ALNYLAM PHARMACEUTICALS COM Call 7,500 2,063 n/a n/a n/a
2024-08-14 2024-06-30 13F ALNYLAM PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2024-05-15 2024-03-31 13F ALNYLAM PHARMACEUTICALS COM Call 2,300 -62.30 344 -70.61 n/a n/a n/a
2024-02-14 2023-12-31 13F ALNYLAM PHARMACEUTICALS COM Call 6,100 -74.90 1,168 -72.88 n/a n/a n/a
2023-11-14 2023-09-30 13F ALNYLAM PHARMACEUTICALS COM Call 24,300 -46.24 4,304 -49.88 n/a n/a n/a
2023-08-14 2023-06-30 13F ALNYLAM PHARMACEUTICALS COM Call 45,200 8,585 n/a n/a n/a
2023-05-15 2023-03-31 13F ALNYLAM PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2023-02-14 2022-12-31 13F ALNYLAM PHARMACEUTICALS COM Call 17,900 4,254 n/a n/a n/a
2022-11-14 2022-09-30 13F ALNYLAM PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2022-08-15 2022-06-30 13F ALNYLAM PHARMACEUTICALS COM Call 50,800 7,409 n/a n/a n/a
2022-05-16 2022-03-31 13F ALNYLAM PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2022-02-14 2021-12-31 13F ALNYLAM PHARMACEUTICALS COM Call 51,000 -21.54 8,649 -29.53 n/a n/a n/a
2021-11-15 2021-09-30 13F ALNYLAM PHARMACEUTICALS COM Call 65,000 -35.00 12,273 -27.60 n/a n/a n/a
2021-08-16 2021-06-30 13F ALNYLAM PHARMACEUTICALS COM Call 100,000 100.00 16,952 140.11 n/a n/a n/a
2021-05-17 2021-03-31 13F ALNYLAM PHARMACEUTICALS COM Call 50,000 42.86 7,060 55.20 n/a n/a n/a
2021-02-16 2020-12-31 13F ALNYLAM PHARMACEUTICALS COM Call 35,000 -66.67 4,549 -70.24 n/a n/a n/a
2020-11-16 2020-09-30 13F ALNYLAM PHARMACEUTICALS COM Call 105,000 15,288 n/a n/a n/a
2013-11-14 2013-09-30 13F ALNYLAM PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2013-08-14 2013-06-30 13F ALNYLAM PHARMACEUTICALS COM Call 20,400 632 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F ALNYLAM PHARMACEUTICALS COM Put 22,800 1,325.00 7,544 1,086.01 n/a n/a n/a
2026-02-17 2025-12-31 13F ALNYLAM PHARMACEUTICALS COM Put 1,600 -15.79 636 -26.56 n/a n/a n/a
2025-11-14 2025-09-30 13F ALNYLAM PHARMACEUTICALS COM Put 1,900 26.67 866 77.10 n/a n/a n/a
2025-08-14 2025-06-30 13F ALNYLAM PHARMACEUTICALS COM Put 1,500 -82.35 489 -78.69 n/a n/a n/a
2025-05-15 2025-03-31 13F ALNYLAM PHARMACEUTICALS COM Put 8,500 -36.09 2,295 -26.65 n/a n/a n/a
2025-02-14 2024-12-31 13F ALNYLAM PHARMACEUTICALS COM Put 13,300 -20.36 3,130 -31.87 n/a n/a n/a
2024-11-14 2024-09-30 13F ALNYLAM PHARMACEUTICALS COM Put 16,700 4,593 n/a n/a n/a
2024-08-14 2024-06-30 13F ALNYLAM PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2024-05-15 2024-03-31 13F ALNYLAM PHARMACEUTICALS COM Put 4,500 673 n/a n/a n/a
2024-02-14 2023-12-31 13F ALNYLAM PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2023-11-14 2023-09-30 13F ALNYLAM PHARMACEUTICALS COM Put 8,700 -86.66 1,541 -87.56 n/a n/a n/a
2023-08-14 2023-06-30 13F ALNYLAM PHARMACEUTICALS COM Put 65,200 12,384 n/a n/a n/a
2022-05-16 2022-03-31 13F ALNYLAM PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2022-02-14 2021-12-31 13F ALNYLAM PHARMACEUTICALS COM Put 9,500 1,611 n/a n/a n/a
2016-05-16 2016-03-31 13F ALNYLAM PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2016-02-16 2015-12-31 13F ALNYLAM PHARMACEUTICALS COM Put 50,000 4,707 n/a n/a n/a
2015-08-14 2015-06-30 13F ALNYLAM PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2015-05-15 2015-03-31 13F ALNYLAM PHARMACEUTICALS COM Put 200,000 20,884 n/a n/a n/a
2014-11-14 2014-09-30 13F ALNYLAM PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2014-08-14 2014-06-30 13F ALNYLAM PHARMACEUTICALS COM Put 22,200 217.14 1,402 211.56 n/a n/a n/a
2014-02-14 2013-12-31 13F ALNYLAM PHARMACEUTICALS COM Put 7,000 450 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.